These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Assessing the risk of ovulation in interaction studies of drugs and oral contraceptives. de la Rey N; Schall R; Luus HG; Meyer BH; Müller FO Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):435-9. PubMed ID: 8225692 [TBL] [Abstract][Full Text] [Related]
24. Oral contraceptives and venous thromboembolism. Skegg D N Z Med J; 2000 Sep; 113(1117):385. PubMed ID: 11050907 [No Abstract] [Full Text] [Related]
36. Oral contraceptives and the risk of death from breast cancer. Wingo PA; Austin H; Marchbanks PA; Whiteman MK; Hsia J; Mandel MG; Peterson HB; Ory HW Obstet Gynecol; 2007 Oct; 110(4):793-800. PubMed ID: 17906011 [TBL] [Abstract][Full Text] [Related]
37. Fracture risk in very young women using combined oral contraceptives. Vestergaard P; Rejnmark L; Mosekilde L Contraception; 2008 Nov; 78(5):358-64. PubMed ID: 18929731 [TBL] [Abstract][Full Text] [Related]
38. [Oral ovariostatic steroids]. D'Andrea R Ann Sanita Pubblica; 1967; 28(4):791-829. PubMed ID: 5606698 [No Abstract] [Full Text] [Related]
40. [Specialists should decide if oral contraceptives are suitable in cases of predisposition to thrombosis]. Strandberg K; Victor A Lakartidningen; 1996 Jan; 93(3):118. PubMed ID: 8569316 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]